In vitro activation of human blood mononuclear cells (Shenzhen Zhongxing Yangfan Bio-Engineering)
体外激活人血单个核细胞（深圳市中兴扬帆生物工程）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameIn vitro activation of human blood mononuclear cells (Shenzhen Zhongxing Yangfan Bio-Engineering)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesShenzhen Zhongxing Yangfan Bio-Engineering Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesShenzhen Zhongxing Yangfan Bio-Engineering Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A